D.E. Shaw & Co
LKFT

D.E. Shaw & Co’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

D.E. Shaw & Co’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.47M Sell
215,718
-59,281
-22% -$1.96M ﹤0.01% 1983
2025
Q4 		$8.99M Buy
274,999
+73,830
+37% +$2.38M ﹤0.01% 1857
2025
Q3 		$6.97M Buy
201,169
+47,984
+31% +$1.53M ﹤0.01% 1946
2025
Q2 		$4.29M Buy
153,185
+90,165
+143% +$2.42M ﹤0.01% 2140
2025
Q1 		$1.58M Buy
+63,020
New +$1.59M ﹤0.01% 2779
2024
Q3 		– Sell
-16,780
Closed -$416K – 4662
2024
Q2 		$416K Sell
16,780
-34,893
-68% -$990K ﹤0.01% 3738
2024
Q1 		$1.66M Sell
51,673
-23,967
-32% -$891K ﹤0.01% 2763
2023
Q4 		$3.07M Buy
75,640
+18,295
+32% +$673K ﹤0.01% 2319
2023
Q3 		$1.98M Buy
57,345
+40,798
+247% +$1.59M ﹤0.01% 2576
2023
Q2 		$673K Buy
+16,547
New +$675K ﹤0.01% 3290
2023
Q1 		– Sell
-59,996
Closed -$2.66M – 4597
2022
Q4 		$2.66M Sell
59,996
-66,138
-52% -$2.78M ﹤0.01% 2686
2022
Q3 		$5.38M Buy
126,134
+5,411
+4% +$277K 0.01% 2006
2022
Q2 		$6.74M Buy
120,723
+77,508
+179% +$4.6M 0.01% 1785
2022
Q1 		$2.68M Sell
43,215
-94,125
-69% -$5.76M ﹤0.01% 3014
2021
Q4 		$7.57M Buy
137,340
+539
+0.4% +$28.1K 0.01% 1945
2021
Q3 		$7.2M Buy
136,801
+69,710
+104% +$4.14M 0.01% 1786
2021
Q2 		$4.62M Buy
67,091
+62,719
+1,435% +$4.78M ﹤0.01% 2125
2021
Q1 		$337K Buy
+4,372
New +$403K ﹤0.01% 3661
2020
Q4 		– Sell
-9,348
Closed -$1.33M – 4002
2020
Q3 		$1.33M Buy
9,348
+4,141
+80% +$690K ﹤0.01% 2671
2020
Q2 		$1.03M Sell
5,207
-866
-14% -$179K ﹤0.01% 2907
2020
Q1 		$1.19M Buy
6,073
+2,373
+64% +$511K ﹤0.01% 2602
2019
Q4 		$765K Buy
+3,700
New +$684K ﹤0.01% 3165
2019
Q3 		– Sell
-3,208
Closed -$414K – 3882
2019
Q2 		$414K Sell
3,208
-19,691
-86% -$2.34M ﹤0.01% 3159
2019
Q1 		$2.7M Buy
22,899
+3,806
+20% +$384K ﹤0.01% 1953
2018
Q4 		$1.75M Buy
19,093
+14,893
+355% +$1.51M ﹤0.01% 2264
2018
Q3 		$472K Buy
+4,200
New +$444K ﹤0.01% 3145

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co's LKFT Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 22% in Q1 2026, selling an estimated $1.96M and leaving 215,718 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

D.E. Shaw & Co first reported a position in LKFT in Q3 2018 and has held it in 26 quarters since. The position peaked at $8.99M in Q4 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • D.E. Shaw & Co held 215,718 shares of Lakefront Biotherapeutics American Depositary Shares worth $6.47M as of Q1 2026.
  • D.E. Shaw & Co sold 59,281 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $1.96M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1983 holding.
  • D.E. Shaw & Co first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 26 quarters since.
  • D.E. Shaw & Co's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.99M in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.